Display options
Cite
Papakostas Y, Markianos M, Papadimitriou G, et al. Thyrotropin and Prolactin Secretion During ECT: Implications for the Mechanism of ECT Action. Convuls Ther. 1990;6(3):214-220
Papakostas, Y., Markianos, M., Papadimitriou, G., & Stefanis, C. (1990). Thyrotropin and Prolactin Secretion During ECT: Implications for the Mechanism of ECT Action. Convulsive therapy, 6(3), 214-220.
Papakostas, Yiannis, et al. "Thyrotropin and Prolactin Secretion During ECT: Implications for the Mechanism of ECT Action." Convulsive therapy vol. 6,3 (1990): 214-220.
Papakostas Y, Markianos M, Papadimitriou G, Stefanis C. Thyrotropin and Prolactin Secretion During ECT: Implications for the Mechanism of ECT Action. Convuls Ther. 1990;6(3):214-220. PMID: 11941070.
Copy Download .nbib Format: NLM
Share it on

Convuls Ther. 1990;6(3):214-220.

Thyrotropin and Prolactin Secretion During ECT: Implications for the Mechanism of ECT Action.

Convulsive therapy

Yiannis Papakostas, Manolis Markianos, George Papadimitriou, Costas Stefanis

Affiliations

  1. Athens University Medical School Psychiatric Clinic, Eginition Hospital, Athens, Greece.

PMID: 11941070

Abstract

The effect of electroconvulsive therapy (ECT) on serum thyrotropin (TSH) and prolactin (PRL) was systematically investigated in two studies: a simulated ECT (SECT) versus real ECT controlled design, and one in which a more sensitive TSH assay was used. In addition to the expected PRL response, a small but consistent TSH increase was demonstrated, especially when the new TSH assay was used. The implications of these findings concerning the underlying ECT mechanisms mediating these effects are discussed and the involvement of thyrotropin-releasing hormone (TRH) and serotonin is stressed.

Publication Types